Hologic reports Q4 EPS $1.00, consensus $1.01

Reports Q4 revenue $987.9M, consensus $976.7M. “We delivered strong fiscal 2024 results, reinforcing our track record of durable performance with another solid quarter of growth,” said Steve MacMillan, Hologic’s (HOLX) chairman, president, and chief executive officer. “Each year we grow stronger, leveraging our leading brands to drive diverse revenue growth and industry leading margins, while generating exceptional cash flow. We are excited for 2025, as we continue to drive market creation with our intense focus on workflow efficiency and automation, ultimately making a difference for our customers and patients worldwide.”